Global Peri-Implantitis Market Worth USD 1.89 Billion by 2030 | CAGR of 8.90%

Introduction

Dental implants that have replaced missing or extracted teeth are affected by peri-implantitis, an inflammatory condition that affects the tissue surrounding the implants. The condition known as peri-implant disease refers to the occurrence of infection and subsequent degradation of the soft tissue surrounding a dental implant. It might cause pain, edema, and difficulty biting and chewing. It is typically caused by poor oral hygiene and is treatable with deep cleaning and antimicrobial therapy.

Market Dynamics

Technological Advancement Drives the Global Market

The use of cutting-edge technology and techniques has sped up, improved, and simplified dentists' operations and made dental procedures faster and less unpleasant for patients. As a result, technical improvements in the dental business benefit both practitioners and patients. Implants aid in the restoration of patients' jaws with fixed teeth. They are currently widely used by the dentistry profession. Implant-based tooth reconstruction is very simple when the bone density is adequate. The alveolus experiences bone resorption and atrophy when a patient is missing teeth. The process required a three to four-month wait before caps could be replaced. This drives the global market.

Potential in Untapped Market Creates Tremendous Opportunities

Dentists can improve an individual's dental health and quality of life by providing an affordable and accessible option. Dental implant providers should ensure they have the appropriate expertise, resources, and infrastructure to successfully manage the issue and provide the patient with the correct treatment. Likewise, dental implant companies should train local dentists in-depth to treat patients properly and spread awareness of the advantages of dental implants in underserved areas. Such factors create opportunities for market growth.

Regional Analysis

Europe is the most significant global peri-implantitis market shareholder and is expected to grow significantly over the forecast period. This is because there are more patients with periodontal conditions, there have been technical advancements, and more people are becoming aware of dental implants and their associated diseases. European National Health Services cover dental implants and related therapies for people with severe periodontal diseases that damage the tooth's supporting structures. As a result, the regional peri-implantitis market is expanding.

The European peri-implantitis market is also being driven by an increase in the prevalence of peri-implantitis, an increase in the geriatric population, an increase in the number of dental issues and oral diseases, a well-established healthcare infrastructure, and promising reimbursement policies.

Key Highlights

• The global peri-implantitis market was valued at 0.95 billion in 2022. It is estimated to reach an expected value of USD 1.89 billion by 2031, registering a CAGR of 8.09% during the forecast period (2022-2031).
• Based on method, the peri-implantitis market is segmented into surgical (bone regeneration, open flap debridement, and implantoplasty) and non-surgical (mechanical debridement, laser debridement, antibiotics, and others). The surgical segment dominates the global market and is expected to grow significantly over the forecast period.
• Based on end-user, the global peri-implantitis market is segmented into hospitals and clinics. The hospital category dominated the market and will likely continue this trend during the forecast period.
• Europe is the most significant global peri-implantitis market shareholder and is expected to grow significantly over the forecast period.

Competitive Players

Competitive Players

The key players in the global peri-implantitis market include Straumann, Nobel Bio Care, Dentsply Sirona, BioHorizons, MIS Implants Technologies Ltd., Neoss, Osstem Implant, Biotech Dental, and Zimmer Biomet.

Recent Developments

Market News

• In May 2023, Straumann announced the full acquisition of GalvoSurge, a Swiss medical device producer in dentistry. The acquired company focused on implant care and maintenance solutions, presenting a novel idea to help with peri-implantitis treatment. The device is CE-marked and was released to the market in 2020.
• In March 2023, Dentsply Sirona launched the DS OmniTaper Implant System® at the EAO Congress in Geneva, Switzerland, combining proven technology with breakthroughs for implant treatment in nearly all clinical circumstances. A straightforward drilling process for reduced chair time and a pre-mounted TempBase for fast restorations and efficient workflows distinguish the implant system.

Segmentation

Global Peri-implantitis Market: Segmentation

By Method

• Surgical
  • Bone Regeneration
  • Open Flap Debridement
  • Implantoplasty
• Non-Surgical
  • Mechanical Debridement
  • Laser Debridement
  • Antibiotics
  • Others

By End-User

• Hospital
• Clinics

By Regions

• North America
• Europe
• Asia-Pacific
• Latin America
• The Middle East and Africa